Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-02-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2008-07-167155PMID 18945961
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Helicobacter pylori infection.

  2009cited by this paper
• Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

  2009cited by this paper
• Helicobacter pylori infection.

  2009cited by this paper
• Helicobacter pylori Infection Stimulates Plasminogen Activator Inhibitor 1 Production by Gastric Epithelial Cells

  2008influential reference
• Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients.

  2008cited by this paper
• Immune Response to CagA Protein is Associated with Improved Platelet Count After Helicobacter pylori Eradication in Patients with Idiopathic Thrombocytopenic Purpura

  2007cited by this paper
• Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura

  2007cited by this paper
• Proof of an Association between Helicobacter pylori and Idiopathic Thrombocytopenic Purpura in Latin America

  2007cited by this paper
• Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets.

  2007cited by this paper
• Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles.

  2007cited by this paper
• Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura

  2007cited by this paper
• Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis.

  2007influential reference
• Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico.

  2007cited by this paper
• Hemostasis, Thrombosis, and Vascular Biology

  2007cited by this paper
• The long‐term efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura

  2007cited by this paper
• Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.

  2006cited by this paper
• Platelet Activation in Helicobacter pylori-Associated Idiopathic Thrombocytopenic Purpura: Eradication Reduces Platelet Activation but Seldom Improves Platelet Counts

  2006cited by this paper
• Overview: Helicobacter pylori and Extragastric Disease

  2006cited by this paper
• Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura

  2006cited by this paper
• The Efficacy of Helicobacter pylori Eradication in the Treatment of Idiopathic Thrombocytopenic Purpura – The First Study in Turkey

  2006cited by this paper
• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

  2006cited by this paper
• Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: Correlation with Helicobacter pylori infection and response to eradication treatment

  2005influential reference
• Is Eradication Therapy Useful as the First Line of Treatment in Helicobacter pylori-Positive Idiopathic Thrombocytopenic Purpura? Analysis of 207 Eradicated Chronic ITP Cases in Japan

  2005cited by this paper
• Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura—A Randomized Controlled Trial

  2005influential reference
• Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.

  2005cited by this paper
• Helicobacter pylori eradication: Novel therapy for immune thrombocytopenic purpura? A review of the literature

  2005influential reference
• Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan

  2005influential reference
• Helicobacter pylori and idiopathic thrombocytopenic purpura.

  2004cited by this paper
• Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori‐associated chronic idiopathic thrombocytopenic purpura

  2004influential reference
• Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.

  2004cited by this paper
• Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?

  2004influential reference
• The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura

  2004cited by this paper
• Characteristics of Helicobacter pylori‐Induced Gastritis and the Effect of H. pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura

  2004cited by this paper
• Measurement of observer agreement.

  2003influential reference
• Can Eradication Therapy for Helicobacter pylori Really Improve the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review

  2003influential reference
• Platelet Recovery in Patients with Idiopathic Thrombocytopenic Purpura after Eradication of Helicobacter Pylori

  2003influential reference
• Measuring inconsistency in meta-analyses

  2003influential reference
• T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy

  2003cited by this paper
• Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura

  2002influential reference
• Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura

  2002influential reference
• Natural history and epidemiology of Helicobacter pylori infection

  2002cited by this paper
• ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection.

  2001influential reference
• Helicobacter pylori CagA: Analysis of Sequence Diversity in Relation to Phosphorylation Motifs and Implications for the Role of CagA as a Virulence Factor

  2001cited by this paper
• Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura

  2001influential reference
• Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections.

  2000influential reference
• Geographic distribution of vacA allelic types of Helicobacter pylori.

  1999cited by this paper
• Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori.

  1998cited by this paper
• Country‐specific constancy by age in cagA+ proportion of Helicobacter pylori infections

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997influential reference
• Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

  1996influential reference
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996influential reference
• Meta-analysis in clinical trials.

  1986influential reference
• On the age distribution of cancer of the lung.

  1954cited by this paper
• The combination of estimates from different experiments.

  1954influential reference
• Transformations Related to the Angular and the Square Root

  1950influential reference

• Association between autoimmune thyroid disease and presence of CagA and gastric intestinal metaplasia among patients with H. pylori: a cross-sectional endoscopic study.

  2026cites this paper
• Is a Functional Cure Possible in Autoimmune Diseases? Evidence from Trigger Eradication, Transplantation, and Cellular Therapies

  2025influential citation
• Iraqi consensus recommendations for the diagnosis and management of immune thrombocytopenia

  2025cites this paper
• Management of Helicobacter pylori Infection: Myanmar Consensus Report

  2025cites this paper
• Helicobacter pylori Across Continents: Contrasts in Epidemiology, Genetics, Clinical Impact, and Management Between East and West

  2025cites this paper
• Revisiting the Role of Helicobacter Pylori in Immune Thrombocytopenia: Insights from a Tertiary Care Centre in India

  2025cites this paper
• A Case of Severe Thrombocytopenia after Laparoscopic Cholecystectomy with Diagnostic Difficulties

  2025cites this paper
• Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Causal Relationship between Helicobacter Pylori Antibodies and Immune Thrombocytopenia: A Mendelian Randomization Study

  2024cites this paper
• The Aging Stomach: Clinical Implications of H. pylori Infection in Older Adults—Challenges and Strategies for Improved Management

  2024cites this paper
• Helicobacter pylori in gastrointestinal manifestation of systemic sclerosis

  2024cites this paper
• The intestinal flora: The key to unraveling heterogeneity in immune thrombocytopenia?

  2024cites this paper
• The first national pediatric immune thrombocytopenia registry in Iran: research protocol and preliminary study results

  2024cites this paper
• Comparison of platelet transfusion effectiveness between Helicobacter pylori‐positive and ‐negative immune thrombocytopenia

  2024cites this paper
• The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients

  2024cites this paper
• Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit

  2024cites this paper
• Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective

  2024cites this paper
• Impact of Helicobacter pylori Infection upon the Evolution and Outcome of Pediatric Immune Thrombocytopenic Purpura: A Comprehensive Review

  2023cites this paper
• Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

  2023cites this paper
• Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges

  2023cites this paper
• Review on Helicobacteriosis Associated Diseases

  2023influential citation
• The Effect of Helicobacter pylori Density on Serum Vitamin B12 and Folate Levels in Patients With Non-atrophic Gastritis

  2023cites this paper
• Helicobacter pylori infection in children with immune thrombocytopenia

  2023cites this paper
• How I Diagnose and Treat Thrombocytopenia in the Geriatric Patient.

  2023cites this paper
• Focusing on Helicobacter pylori infection in the elderly

  2023cites this paper
• Consensus recommendations for the screening, diagnosis, and management of Helicobacter pylori infection in Hong Kong.

  2023cites this paper
• Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology

  2023cites this paper
• Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study

  2022cites this paper
• Diagnosis of immune thrombocytopenia, including secondary forms, and selection of second-line treatment

  2022cites this paper
• Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis

  2022cites this paper
• Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia

  2022cites this paper
• Epidemiology of Helicobacter pylori

  2022cites this paper
• Rilzabrutinib in Immune Thrombocytopenia. Reply.

  2022cites this paper
• Helicobacter pylori roles in haematology disease pathogenesis

  2022cites this paper
• Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001

  2022cites this paper
• Helicobacter pylori-Related Extraintestinal Manifestations—Myth or Reality

  2022cites this paper
• Discussion on the common controversies of Helicobacter pylori infection

  2022cites this paper
• Current approaches for the diagnosis and management of immune thrombocytopenia.

  2022cites this paper
• Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.

  2022cites this paper
• Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for H. pylori Di

  2022cites this paper
• Management of Helicobacter pylori infection

  2022cites this paper
• Purpura thrombopénique immunologique

  2022cites this paper
• Impact of eradication therapy of Helicobacter pylori in children with chronic immune thrombocytopenic purpura

  2021cites this paper
• Benefits of Helicobacter pylori Eradication on Extragastric Diseases

  2021cites this paper
• A Review on Secondary Immune Thrombocytopenia in Malaysia

  2021cites this paper
• Helicobacter pylori in Childhood

  2021cites this paper
• A case of gastric cancer that developed thrombocytopenia during treatment with nivolumab

  2021cites this paper
• Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis

  2021cites this paper
• Importance of testing for Helicobacter pylori in patients with immune thrombocytopenia

  2021cites this paper
• Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa

  2021cites this paper
• Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia

  2021cites this paper
• Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East

  2021cites this paper
• Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology

  2021cites this paper
• An Unusual Cause of Secondary ITP in a 34-Year-Old Hispanic Male

  2021cites this paper
• Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults

  2021cites this paper
• Primary immune thrombocytopenia in children

  2021cites this paper
• The treatment of immune thrombocytopenia (ITP)—focus on thrombopoietin receptor agonists

  2021influential citation
• Helicobacter pylori and skin disorders: a comprehensive review of the available literature.

  2020cites this paper
• International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee

  2020cites this paper
• Effect of Helicobacter pylori infection on the first-line treatment outcomes in patients with immune thrombocytopenic purpura.

  2020cites this paper
• Helicobacter pylori Infection: When Should It Be Treated?

  2020cites this paper
• Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia

  2020cites this paper
• How I approach new onset thrombocytopenia

  2020cites this paper
• Helicobacter pylori eradication therapy in patients with immune thrombocytopenic purpura: a single-center experience

  2020cites this paper
• Hellenic consensus on Helicobacter pylori infection

  2020cites this paper
• Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia

  2020cites this paper
• Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision

  2020cites this paper
• High Effectiveness of a 14-Day Concomitant Therapy for Helicobacter pylori Treatment in Primary Care. An Observational Multicenter Study

  2020cites this paper
• Helicobacter pylori and Hematologic Diseases

  2020cites this paper
• Immune thrombocytopenia is different from thrombotic thrombocytopenic purpura

  2020cites this paper
• Severe Immune Thrombocytopenia Complicated by Intracerebral Haemorrhage Associated with Coronavirus Infection: A Case Report and Literature Review

  2019cites this paper
• Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center

  2019influential citation
• Helicobacter pylori: An Underrated Cause of Immune Thrombocytopenic Purpura. A Comprehensive Review

  2019cites this paper
• An Updated Approach to Evaluation and Treatment of Helicobacter pylori Infection

  2019cites this paper
• Features of Extragastrointesinal Signs of Helicobacter Pylori Infection

  2019cites this paper
• Immune thrombocytopenia associated with Helicobacter pylori – unclear associative mechanisms

  2019cites this paper
• Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome

  2019cites this paper
• Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP)

  2019cites this paper
• O Impacto da Erradicação de Helicobacter pylori em Doentes com Trombocitopenia Imune

  2019influential citation
• N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.

  2019cites this paper
• Helicobacter pylori and hematological disorders.

  2019cites this paper
• Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention

  2019influential citation
• Clinical characteristics of insulin resistance syndromes: A nationwide survey in Japan

  2019cites this paper
• Management of Helicobacter pylori in Patients with Immune Thrombocytopenia

  2019cites this paper
• The Potential of Plants of the Genus Syzygium (Myrtaceae) for the Prevention and Treatment of Arthritic and Autoimmune Diseases

  2019cites this paper
• Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

  2019cites this paper
• The Relation of Cytotoxin-Associated Gene-A Seropositivity with Vitamin B12 Deficiency in Helicobacter pylori-Positive Patients

  2019cites this paper
• Status of vaccine research and development for Helicobacter pylori

  2019cites this paper
• Acquired Glanzmann thrombasthenia: From antibodies to anti-platelet drugs.

  2019cites this paper
• Immune thrombocytopenia

  2019cites this paper
• Immune Thrombocytopenia

  2019cites this paper
• H. pylori infection and extra-gastroduodenal diseases

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Chapter 3 Helicobacter pylori and Hematologic Diseases

  2018cites this paper
• Emerging Concepts in Immune Thrombocytopenia

  2018cites this paper
• Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI

  2018cites this paper
• Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia

  2018cites this paper
• Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira – 2018

  2018cites this paper
• The fourth Mexican consensus on Helicobacter pylori.

  2018cites this paper
• The fourth Mexican consensus on Helicobacter pylori

  2018cites this paper